Atrial fibrillation

A large Cleveland Clinic study has shown that weight-loss surgery performed in patients with type 2 diabetes and obesity is...


Atrial fibrillation is the most frequent sustained arrhythmia. Atrial fibrillation often recurs after restoration of normal sinus rhythm. Antiarrhythmic drugs...


Edoxaban ( Lixiana ) in combination with a P2Y12 inhibitor is noninferior to standard triple therapy for preventing bleeding in...


The aim of study was to compare effectiveness and safety of non-vitamin K antagonist oral anticoagulants ( NOACs ) versus...


Although procedure-related deaths during index admission following catheter ablation of atrial fibrillation ( AF ) have been reported to be...


Tthe US Food and Drug Administration ( FDA ) has approved Calquence ( Acalabrutinib ) for adult patients with chronic...


Nonvitamin K antagonist oral anticoagulants ( NOACs ) are alternatives to Warfarin ( Coumadin ) in patients with nonvalvular atrial...


The results from an independent retrospective comparative study, published in the American Journal of Medicine, have shown that Dabigatran was...


Evidence suggests that atrial fibrillation ( AF ) is associated with a higher risk for cognitive impairment and dementia, with...


It is well established that atrial fibrillation increases the risk of clinical stroke by four- to five-fold, and patients with...


Longitudinal studies have shown that dementia is more common in patients diagnosed with atrial fibrillation ( AF ) even in...


Since the precise mechanism(s) of cognitive disorders in patients with atrial fibrillation ( AF ) is not fully known, the...


A study has assessed the relationship between atrial fibrillation and outcomes in the TOPCAT ( Treatment of Preserved Cardiac...


Beta-blockers are the cornerstone of therapy for heart failure; however, the effects of these drugs on the prognosis of patients...


In acute coronary syndrome ( ACS ), potassium imbalance at admission has been associated with in-hospital arrhythmias, cardiac arrest, and...


Anthracycline-induced cardiotoxicity was first reported in early 1970s. Since then, there has been increasing recognition of its association with poor...


The PARP inhibitor, Olaparib ( Lynparza ) has shown clinical activity in subsets of recurrent ovarian cancer patients. Researchers have...


Findings from a real-world data analysis of the U.S. Medicare database comparing the risk of stroke or systemic embolism and...


Amid growing uncertainty about the safety of Digoxin, a commonly used heart drug, a study led by Duke Clinical Research...


As the Zika virus continues to spread globally, new evidence has emerged about the virus's potentially detrimental effects on the...